Topic · 1 report

340B Program

RegulationWatch reporting on 340b program matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. 340B Program

    Missouri orders Eli Lilly to drop 340B claims-data condition after hospital cut-off

    Missouri Attorney General Catherine Hanaway sent Eli Lilly a cease-and-desist letter alleging its requirement that 340B hospitals hand over claims data violates state consumer protection law. Lilly had cut University of Missouri Health Care off from 340B pricing in July.